Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

The pharmaceutical industry is under growing scrutiny from regulators when it comes to CAPA effectiveness checks. This blog explores how to improve root cause analysis, ensure closed-loop CAPA systems, and avoid repeat findings in GMP audits.
Explore and uncover the key aspects of efficient pharmaceutical internal audit processes, while also delving into the valuable ISO 19011 guidelines. Understand the importance of thorough audit program preparation, as it is essential for achieving success in your auditing efforts
FDA drug recalls play a critical role in protecting public health by ensuring that unsafe or defective products are removed from the market. Staying ahead of compliance challengesFDA recalls are costly, but proactive compliance measures can significantly reduce the risks.
Discover the essential guide to navigating notified body inspections for medical devices with our 10 easy steps. Ensure compliance, streamline the process, and achieve success with expert insights and actionable strategies.
The FDA’s Bioresearch Monitoring Program (BIMO) is critical for maintaining the integrity of clinical trials. In this blog, we explore the nuances of BIMO inspections and offer detailed guidance for clinical researchers to navigate these complex evaluations.
Understanding FDA inspections is crucial for businesses in the food & drug industry. This blog breaks down the different types of inspections, the post-inspection process, and how to be prepared for a smooth FDA visit.
Prepare for a successful GMP inspection by conducting internal audits, implementing strong quality control systems, staying updated on regulations, utilizing technology, and conducting mock inspections. These steps will help pharmaceutical companies ensure compliance, uphold quality, and demonstrate commitment to patient
FDA warning letters typically follow inspections where deviations or violations of regulations, such as those related to data integrity are discovered. During inspections, auditors document these deviations using Form 483. While Forms 483 and FDA Warning Letters are distinct, the
In the pharmaceutical industry, GMP inspections ensure quality and compliance, demonstrating commitment to safety and building trust with healthcare professionals and patients. Understanding the inspection process, guidelines, and common deficiencies is crucial for upholding industry standards and ensuring patient safety.